The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using …

T Roy, ST Boateng, MB Uddin, S Banang-Mbeumi… - Cells, 2023 - mdpi.com
The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin
(mTOR) signaling pathway has been implicated in various immune-mediated inflammatory …

Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans

D Zingue, A Bouam, RBD Tian… - Clinical microbiology …, 2018 - Am Soc Microbiol
Buruli ulcer is a noncontagious disabling cutaneous and subcutaneous mycobacteriosis
reported by 33 countries in Africa, Asia, Oceania, and South America. The causative agent …

How to diagnose acute appendicitis: ultrasound first

G Mostbeck, EJ Adam, MB Nielsen, M Claudon… - Insights into …, 2016 - Springer
Acute appendicitis (AA) is a common abdominal emergency with a lifetime prevalence of
about 7%. As the clinical diagnosis of AA remains a challenge to emergency physicians and …

The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study

TW Winkler, AE Justice, M Graff, L Barata… - PLoS …, 2015 - journals.plos.org
Genome-wide association studies (GWAS) have identified more than 100 genetic variants
contributing to BMI, a measure of body size, or waist-to-hip ratio (adjusted for BMI …

Integrated control and management of neglected tropical skin diseases

O Mitjà, M Marks, L Bertran, K Kollie… - PLoS neglected …, 2017 - journals.plos.org
Neglected tropical diseases (NTDs) are communicable diseases that occur under conditions
of poverty and are concentrated almost exclusively in impoverished populations in the …

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 …

RO Phillips, J Robert, KM Abass, W Thompson… - The Lancet, 2020 - thelancet.com
Background Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans
infection that damages the skin and subcutis. It is most prevalent in western and central …

[HTML][HTML] Increased severity and spread of Mycobacterium ulcerans, Southeastern Australia

AYC Tai, E Athan, ND Friedman, A Hughes… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
Reported cases of Mycobacterium ulcerans disease (Buruli ulcer) have been increasing in
southeastern Australia and spreading into new geographic areas. We analyzed 426 cases …

[PDF][PDF] Buruli ulcer: history and disease burden

K Röltgen, G Pluschke - Buruli ulcer: Mycobacterium ulcerans …, 2019 - library.oapen.org
The first description of chronic skin ulcers consistent with the pathology of Mycobacterium
ulcerans infection dates back to the end of the nineteenth century, when the British physician …

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology

M Foulon, M Robbe-Saule, J Manry, L Esnault… - PLoS …, 2020 - journals.plos.org
Mycolactone, a lipid-like toxin, is the major virulence factor of Mycobacterium ulcerans, the
etiological agent of Buruli ulcer. Its involvement in lesion development has been widely …

Epidemiology and disease burden of Buruli ulcer: a review

K Röltgen, G Pluschke - Research and Reports in Tropical …, 2015 - Taylor & Francis
Buruli ulcer (BU) is a neglected tropical skin disease caused by Mycobacterium ulcerans.
Infection foci occur mainly in remote, rural areas of Central and West Africa, but also in …